Affirm (AFRM) Q1 2027 Earnings Call Transcript

Affirm (AFRM) executives discussed growth prospects, funding costs, and agentic shopping during Q1 2027 earnings call. Max Levchin expects 30%+ growth for a long time, citing low e-commerce penetration. Robert O'Hare confirmed a 30% growth floor for the year. Levchin also highlighted Affirm's focus on agentic shopping, emphasizing personalized transaction pricing. Funding costs rose 27 bps quarter-over-quarter but remain down year-on-year, with 70% of on-balance sheet funding fixed-rate.

Original reporting
Published Nov 6, 2026, 2:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Affirm (AFRM) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AFRMBullishMed
01

Why it matters

The guidance sets a clear growth floor and indicates cost discipline, which may attract growth‑oriented investors while prompting analysts to revise forecasts.

02

Market read

Affirm's guidance could drive short‑term price movement and influence sentiment across the BNPL and broader fintech space.

03

What to watch

Potential regulatory scrutiny of BNPL models and competition from traditional lenders could temper upside.

Relevance 7/10Novelty 6/10Timing: post‑earnings today

Background

Affirm (AFRM) held its Q1 2027 earnings call, discussing growth targets, funding cost dynamics, and its proprietary transformer‑based underwriting model.

Company-level read

Ticker impact

$AFRMBullishHigh confidence
Context

Affirm's Q1 2027 earnings call disclosed a full-year growth floor of at least 30% and a modest 27 bps increase in funding costs quarter‑over‑quarter.

Expected impact

likely upward pressure as investors price in stronger growth outlook

Evidence & confidence

The company set a clear 30% growth floor and highlighted fixed‑rate funding, which should support margins and boost investor confidence.

Market effects

Positive for fintech and BNPL sector as Affirm signals resilience and growth despite rising rates.

U.S. fintech stocks may see modest gains.

Limited to U.S. markets; no direct global ripple.

Counterpoint

Higher growth guidance may be optimistic given macro‑rate headwinds; funding cost uptick could erode margins if rates rise further.

Key entities

  • Max Levchin

    Co‑founder and CEO of Affirm, provided guidance on growth and funding costs.

  • Robert O'Hare

    Affirm CFO, discussed funding cost trends and take‑rate metrics.

Related articles

$AFRMMed

Piper Sandler lowers Affirm stock price target to $105 on valuation

Piper Sandler cut its price target on Affirm (AFRM) to $105 from $115, citing valuation changes, while raising its fiscal 2027 EPS estimate to $1.92. Affirm's Q1 results beat expectations with $1.26B revenue and $0.47 EPS, but shares fell 8% after-hours. Analysts note potential upside, with revenue growth of 32% and predicted profitability. Other analysts raised targets to $97 (Scotiabank) and $100 (Needham).

$AFRMHigh

Scotiabank raises Affirm stock price target to $97 on growth outlook

Scotiabank raised its price target on Affirm (AFRM) to $97 from $95, maintaining a Sector Outperform rating. The fintech company reported 30% gross merchandise volume growth, a 4.3% transaction cost take rate, and raised its fiscal 2027 growth floor to 30%. Affirm's Q1 2027 earnings beat expectations with $0.47 EPS on $1.26B revenue. Management noted increased allowance rates and delinquencies but highlighted better loan sale pricing.

$AFRMMed

Needham reiterates Affirm stock rating citing strong growth

Needham reiterated a Buy rating and $100 price target on Affirm (AFRM) after Q1 results beat estimates. Revenue rose 32% to $4.26B, with earnings of $5.53 per share. Affirm Card showed strong growth, but shares fell due to credit cost concerns. InvestingPro notes volatility and potential undervaluation. Q1 2027 earnings of $0.47 per share on $1.26B revenue exceeded expectations, with a 34% GMV increase.